Allkem will merge with Livent to create a New York-listed $US10.6 billion ($15.7 billion) global force in lithium to be chaired by Peter Coleman.
The enlarged business will be 56-44 controlled by Allkem shareholders, who will receive one share in the new company for each Allkem share held.
Loading...